×
About 860 results

ALLMedicine™ Allergic Bronchopulmonary Aspergillosis Center

Research & Reviews  284 results

Allergic bronchopulmonary aspergillosis and aspergilloma.
https://doi.org/10.1016/j.amjmed.2023.01.013
The American Journal of Medicine; Itoh R, Matsumoto S et. al.

Feb 5th, 2023 - Allergic bronchopulmonary aspergillosis and aspergilloma.|2023|Itoh R,Matsumoto S,Uhara K,Yasumoto Y,Tomoda Y,|

Epidemiological Trends in Nontuberculous Mycobacterial Infection among People with Cyst...
https://doi.org/10.1016/j.ijid.2023.01.032
International Journal of Infectious Diseases : IJID : Off... Steindor M, Hafkemeyer S et. al.

Feb 4th, 2023 - People with cystic fibrosis (pwCF) are at risk for infection with nontuberculous mycobacteria (NTM). Epidemiology and screening practice of NTM among pwCF in Germany are largely unknown. We analyzed data of the German CF Registry from 2016 to 2020...

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and Allergic Bronchopulmonary Aspergillosis
https://clinicaltrials.gov/ct2/show/NCT05667662

Feb 2nd, 2023 - The goal of this clinical trial is to learn about PUR1900 as an inhaled, antifungal therapeutic for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma. The main questions it aims to answer are: Is PUR1900 safe ...

Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fu...
https://doi.org/10.1172/JCI161593
The Journal of Clinical Investigation; Schwarz C, Eschenhagen P et. al.

Jan 27th, 2023 - The fungus Aspergillus fumigatus causes a variety of clinical phenotypes in patients with cystic fibrosis (pwCF). T-helper (Th) cells orchestrate immune responses against fungi, but the types of A. fumigatus-specific Th-cells in pwCF and their con...

A case-control study of the effects of Aspergillus clinical phenotypes on pulmonary fun...
https://doi.org/10.1002/ppul.26319
Pediatric Pulmonology; Nayir Buyuksahin H, Dogru D et. al.

Jan 19th, 2023 - There are no precise data about the effect of Aspergillus infection on lung function other than allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (pwCF). Here, we aimed to determine clinical phenotypes caused by Asper...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  28 results

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and Allergic Bronchopulmonary Aspergillosis
https://clinicaltrials.gov/ct2/show/NCT05667662

Feb 2nd, 2023 - The goal of this clinical trial is to learn about PUR1900 as an inhaled, antifungal therapeutic for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma. The main questions it aims to answer are: Is PUR1900 safe ...

A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
https://clinicaltrials.gov/ct2/show/NCT04442269

Jan 17th, 2023 - The primary objective of the study is to evaluate the efficacy of dupilumab on the annualized rate of exacerbations in participants with Allergic Bronchopulmonary Aspergillosis (ABPA). The secondary objectives of the study are: To evaluate the eff...

Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)
https://clinicaltrials.gov/ct2/show/NCT05616338

Dec 5th, 2022 - Asthma is severe when it cannot be controlled with maximum-dose inhaled therapies while management of comorbidities and other precipitating or aggravating factors has been optimized. Allergic bronchopulmonary aspergillosis (ABPA) is a complex bron...

Immune Profiles in CF Fungal Infection
https://clinicaltrials.gov/ct2/show/NCT04476758

Nov 2nd, 2022 - While bacteria are predominant agents in CF lung disease, fungi are often isolated in both sputum and bronchoalveolar lavage fluid (BAL), yet their role in CF is not fully understood. Fungal infection in CF has a wide spectrum of presentations, va...

A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
https://clinicaltrials.gov/ct2/show/NCT02440009

Oct 7th, 2022 - The management of allergic bronchopulmonary aspergillosis (ABPA) includes two important aspects namely institution of immunosuppressive therapy in the form of glucocorticoids to control the immunologic activity, and close monitoring for detection ...

see more →

News  7 results

Five Things You Need to Know About Bronchiectasis
https://www.medscape.com/viewarticle/955069

Jul 22nd, 2021 - Bronchiectasis is a chronic condition characterised by symptoms of persistent or recurrent bronchial sepsis caused by irreversible damage to and dilation of the bronchi.[1] The key principles of the diagnosis and management of bronchiectasis were ...

Fast Five Quiz: How Much Do You Know About Asthma?
https://reference.medscape.com/viewarticle/846001_4

Jun 4th, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

Adult bronchiectasis, asthma therapy, frailty in ILD
https://www.mdedge.com/chestphysician/article/158061/society-news/adult-bronchiectasis-asthma-therapy-frailty-ild

Feb 6th, 2018 - Clinical Research New guidelines for adult bronchiectasis Clinically significant bronchiectasis is a combination of radiologic bronchial dilatation with clinical symptoms. Guidelines on management of adult bronchiectasis were recently published (E.

Management of Asthma in the Military
https://www.mdedge.com/fedprac/article/135491/pulmonology/management-asthma-military
Capt Frederic A. Rawlins III, DO, LTC Jacob F. Collen, MD et. al.

Apr 10th, 2017 - Asthma is a chronic inflammatory disorder of the airways that leads to airflow obstruction and bronchial hyperresponsiveness. Clinical features of asthma include episodic cough, wheeze, and dyspnea, which may resolve with avoidance of triggers or.

European societies issue aspergillosis diagnosis, management guidelines
https://www.mdedge.com/chestphysician/article/105429/infectious-diseases/european-societies-issue-aspergillosis-diagnosis
Neil Osterweil, MDedge News

Dec 23rd, 2015 - European respiratory disease and infectious disease specialists have banded together to issue new clinical guidelines on the diagnosis and management of an uncommon but serious problem: chronic pulmonary aspergillosis (CPA). Pulmonary infections w.

see more →

Patient Education  8 results see all →